// App-Quantinova.ai

1871 : HBsAg and HBcrAg concentrations differ between genotype A1 and A2 HBeAg negative patients with chronic hepatitis B: complexity within sub‐genotypes has implications for newer therapy paradigms

Researchers

Presenter

  • Ivana Carey

Principal Investigators

  • Enoka Gonsalkorala

  • Matthew Bruce

  • Sarah Montague

  • Bo Wang

  • Ruth Byrne

  • Geoffrey M. Dusheiko

  • Kosh Agarwal

Medical Centers

  • Institute of Liver Studies, Kings CollegeHospital NHS Trust, London , United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Infectious Diseases (ID)

Disease

  • Hepatitis B

  • Hepatic fibrosis

Biomarkers

  • Hepatitis B surface antigen

  • Hepatitis B e antigen

  • Hepatitis B core-related antigen

  • Aspartate transaminase-platelet ratio index

Drug/Treatment

  • Desogestrel/ethinyl estradiol

Outcome

  • N/A


Study Design

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A